Results of temperature-controlled radiofrequency tissue volume reduction for the turbinate hypertrophy.
Abstract
OBJECTIVES: To assess the efficacy of temperature-controlled radiofrequency tissue volume reduction (RFTVR) for the inferior turbinate. RESEARCH DESIGNS: Prospective, single-blinded, experimental clinical trial. METHOD: Twenty patients with nasal obstruction secondary to inferior turbinate hypertrophy were enrolled. Nasal obstruction was compared between before and after the treatment (at 1-3 days, 1 week and 6-8 weeks) of RFTVR using subjective symptom scores, physical findings and videotape images. RESULTS: Improvement of nasal symptoms was observed as early as 1 week after the operation. However, significant improvement was obtained at 6-8 weeks. CONCLUSION: RFTVR for the turbinate may be useful as an alternative approach for the treatment of chronic turbinate hypertrophy.
AI evidence extraction
Main findings
Nasal symptom improvement was observed as early as 1 week after radiofrequency tissue volume reduction, with significant improvement at 6–8 weeks post-treatment.
Outcomes measured
- Nasal obstruction/nasal symptoms (subjective symptom scores)
- Physical findings
- Videotape image assessment
Limitations
- Small sample size (n=20)
- Single-blinded design
- Follow-up limited to 6–8 weeks
- No RF exposure parameters (e.g., frequency, dose) reported in abstract
View raw extracted JSON
{
"study_type": "randomized_trial",
"exposure": {
"band": "RF",
"source": "medical procedure (radiofrequency tissue volume reduction)",
"frequency_mhz": null,
"sar_wkg": null,
"duration": null
},
"population": "Patients with nasal obstruction secondary to inferior turbinate hypertrophy",
"sample_size": 20,
"outcomes": [
"Nasal obstruction/nasal symptoms (subjective symptom scores)",
"Physical findings",
"Videotape image assessment"
],
"main_findings": "Nasal symptom improvement was observed as early as 1 week after radiofrequency tissue volume reduction, with significant improvement at 6–8 weeks post-treatment.",
"effect_direction": "benefit",
"limitations": [
"Small sample size (n=20)",
"Single-blinded design",
"Follow-up limited to 6–8 weeks",
"No RF exposure parameters (e.g., frequency, dose) reported in abstract"
],
"evidence_strength": "low",
"confidence": 0.7399999999999999911182158029987476766109466552734375,
"peer_reviewed_likely": "yes",
"keywords": [
"radiofrequency",
"temperature-controlled",
"tissue volume reduction",
"inferior turbinate",
"turbinate hypertrophy",
"nasal obstruction",
"clinical trial"
],
"suggested_hubs": []
}
AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.